FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3036421444> ?p ?o ?g. }

• W3036421444 abstract "Abstract We report on the first regulatory approved clinical trial of a prospective open-label physician-initiated study assessing the safety and efficacy of intradetrusor injected Autologous Muscle Derived Cells (AMDC) treatment for underactive bladder (UAB). 20 non-neurogenic UAB patients were treated. Approximately 50-250 mg of quadriceps femoris muscle was collected using a spirotome 8-gauge needle. The muscles biopsy samples were sent to Cook MyoSite (Pittsburgh, PA) for processing, isolation, and propagation of cells. Research patients received approximately 30 intradetrusor injections of 0.5 mL delivered to the bladder, for a total of 15 mL and 125 million AMDC, performed utilizing a flexible cystoscope under direct vision using topical local anesthesia. Follow-up assessments included adverse events and efficacy via voiding diary and urodynamic testing at 1, 3, 6 & 12-month post-injection. An optional second injection was offered at the end of the 6 months visit. 20 patients received the first injection and all 20 patients requested and received a second injection. Median patient age was 65 years old (range 41-82 years). There were 16 male (80%) and 4 female (20%) patients. Etiology included 7 men (35%) with persistent urinary retention after transurethral resection of the prostate for benign prostatic hyperplasia and 13 patients (65%) with idiopathic chronic urinary retention. At the primary outcome time point of 12 months, 11/19 patients (58%) reported a global response assessment (GRA) ≥ 5, showing slight to marked improvement in their UAB symptoms, compared to 6/20 (30%) patients at 3-months post-injection. No serious procedure or treatment-related adverse events occurred. Noted improvements included: decreased post void residual urine volume, increased voiding efficiency, and decreased catheter use. Intradetrusor injected AMDC as a treatment for UAB was successfully completed in a 20-patient trial without serious adverse event and with signal of efficacy. Cellular therapy may be a promising novel treatment for catheter dependent chronic urinary retention. A multicenter controlled trial is needed to further assess the promise of regenerative medicine in the treatment of lower urinary tract dysfunction." @default.
• W3036421444 created "2020-06-25" @default.
• W3036421444 creator A5013316727 @default.
• W3036421444 creator A5019808095 @default.
• W3036421444 creator A5032099232 @default.
• W3036421444 creator A5042643167 @default.
• W3036421444 creator A5046773465 @default.
• W3036421444 creator A5055878057 @default.
• W3036421444 creator A5057978911 @default.
• W3036421444 creator A5060253377 @default.
• W3036421444 creator A5067821863 @default.
• W3036421444 creator A5076037136 @default.
• W3036421444 date "2020-06-19" @default.
• W3036421444 modified "2023-09-27" @default.
• W3036421444 title "Improved Global Response Outcome After Intradetrusor Injection of Adult Muscle-Derived Cells for the Treatment of Underactive Bladder" @default.
• W3036421444 cites W1862943655 @default.
• W3036421444 cites W1964072377 @default.
• W3036421444 cites W1968553106 @default.
• W3036421444 cites W1982561746 @default.
• W3036421444 cites W2002305277 @default.
• W3036421444 cites W2003002002 @default.
• W3036421444 cites W2004736560 @default.
• W3036421444 cites W2006135211 @default.
• W3036421444 cites W2012802277 @default.
• W3036421444 cites W2034868648 @default.
• W3036421444 cites W2035963411 @default.
• W3036421444 cites W2038898824 @default.
• W3036421444 cites W2038955519 @default.
• W3036421444 cites W2085643579 @default.
• W3036421444 cites W2087032775 @default.
• W3036421444 cites W2110099116 @default.
• W3036421444 cites W2113727679 @default.
• W3036421444 cites W2152730379 @default.
• W3036421444 cites W2157128930 @default.
• W3036421444 cites W2360925739 @default.
• W3036421444 cites W2584131180 @default.
• W3036421444 cites W2774643441 @default.
• W3036421444 cites W2784007403 @default.
• W3036421444 cites W2901123408 @default.
• W3036421444 cites W4256539296 @default.
• W3036421444 doi "https://doi.org/10.1101/2020.06.16.20132779" @default.
• W3036421444 hasPublicationYear "2020" @default.
• W3036421444 type Work @default.
• W3036421444 sameAs 3036421444 @default.
• W3036421444 citedByCount "0" @default.
• W3036421444 crossrefType "posted-content" @default.
• W3036421444 hasAuthorship W3036421444A5013316727 @default.
• W3036421444 hasAuthorship W3036421444A5019808095 @default.
• W3036421444 hasAuthorship W3036421444A5032099232 @default.
• W3036421444 hasAuthorship W3036421444A5042643167 @default.
• W3036421444 hasAuthorship W3036421444A5046773465 @default.
• W3036421444 hasAuthorship W3036421444A5055878057 @default.
• W3036421444 hasAuthorship W3036421444A5057978911 @default.
• W3036421444 hasAuthorship W3036421444A5060253377 @default.
• W3036421444 hasAuthorship W3036421444A5067821863 @default.
• W3036421444 hasAuthorship W3036421444A5076037136 @default.
• W3036421444 hasBestOaLocation W30364214441 @default.
• W3036421444 hasConcept C121608353 @default.
• W3036421444 hasConcept C126322002 @default.
• W3036421444 hasConcept C126894567 @default.
• W3036421444 hasConcept C141071460 @default.
• W3036421444 hasConcept C188816634 @default.
• W3036421444 hasConcept C197934379 @default.
• W3036421444 hasConcept C203092338 @default.
• W3036421444 hasConcept C2776235491 @default.
• W3036421444 hasConcept C2777562237 @default.
• W3036421444 hasConcept C2779091618 @default.
• W3036421444 hasConcept C2779762690 @default.
• W3036421444 hasConcept C2780616540 @default.
• W3036421444 hasConcept C2780768273 @default.
• W3036421444 hasConcept C2909269795 @default.
• W3036421444 hasConcept C535046627 @default.
• W3036421444 hasConcept C71924100 @default.
• W3036421444 hasConceptScore W3036421444C121608353 @default.
• W3036421444 hasConceptScore W3036421444C126322002 @default.
• W3036421444 hasConceptScore W3036421444C126894567 @default.
• W3036421444 hasConceptScore W3036421444C141071460 @default.
• W3036421444 hasConceptScore W3036421444C188816634 @default.
• W3036421444 hasConceptScore W3036421444C197934379 @default.
• W3036421444 hasConceptScore W3036421444C203092338 @default.
• W3036421444 hasConceptScore W3036421444C2776235491 @default.
• W3036421444 hasConceptScore W3036421444C2777562237 @default.
• W3036421444 hasConceptScore W3036421444C2779091618 @default.
• W3036421444 hasConceptScore W3036421444C2779762690 @default.
• W3036421444 hasConceptScore W3036421444C2780616540 @default.
• W3036421444 hasConceptScore W3036421444C2780768273 @default.
• W3036421444 hasConceptScore W3036421444C2909269795 @default.
• W3036421444 hasConceptScore W3036421444C535046627 @default.
• W3036421444 hasConceptScore W3036421444C71924100 @default.
• W3036421444 hasLocation W30364214441 @default.
• W3036421444 hasOpenAccess W3036421444 @default.
• W3036421444 hasPrimaryLocation W30364214441 @default.
• W3036421444 hasRelatedWork W12110873 @default.
• W3036421444 hasRelatedWork W13280625 @default.
• W3036421444 hasRelatedWork W13879451 @default.
• W3036421444 hasRelatedWork W1401080 @default.
• W3036421444 hasRelatedWork W15876507 @default.
• W3036421444 hasRelatedWork W20591331 @default.
• W3036421444 hasRelatedWork W22424037 @default.
• W3036421444 hasRelatedWork W3605267 @default.

• next